Found: 21
Select item for more details and to access through your institution.
Cerebrovascular pattern improved by ozone autohemotherapy: an entropy-based study on multiple sclerosis patients.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Escaping from COVID‐19 emergency accounting on previously infected subjects?
- Published in:
- Journal of Medical Virology, 2022, v. 94, n. 6, p. 2352, doi. 10.1002/jmv.27645
- By:
- Publication type:
- Article
On reaching herd immunity during the COVID-19 pandemic and further issues.
- Published in:
- Journal of Medical Virology, 2022, v. 94, n. 1, p. 24, doi. 10.1002/jmv.27322
- By:
- Publication type:
- Article
Paracetamol in the home treatment of early COVID‐19 symptoms: A possible foe rather than a friend for elderly patients?
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 10, p. 5704, doi. 10.1002/jmv.27158
- By:
- Publication type:
- Article
Oxygen‐ozone autohemotherapy against COVID‐19 needs to fit highly experienced, customized, and standardized protocols to succeed.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 5, p. 2580, doi. 10.1002/jmv.26806
- By:
- Publication type:
- Article
Ozonated water in painful periodontitis and photo biomodulation (PBM) therapy: some comments.
- Published in:
- Lasers in Medical Science, 2024, v. 39, n. 1, p. 1, doi. 10.1007/s10103-024-03990-8
- By:
- Publication type:
- Article
COVID-19 Medical and Pharmacological Management in the European Countries Compared to Italy: An Overview.
- Published in:
- International Journal of Environmental Research & Public Health, 2022, v. 19, n. 7, p. 4262, doi. 10.3390/ijerph19074262
- By:
- Publication type:
- Article
Male vs. Female Differences in Responding to Oxygen–Ozone Autohemotherapy (O 2 -O 3 -AHT) in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 1, p. 173, doi. 10.3390/jcm11010173
- By:
- Publication type:
- Article
Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Greatly Improved Fatigue Symptoms When Treated with Oxygen-Ozone Autohemotherapy.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Ozone in the adjunct medical treatment. The round personality of a molecule with hormetic properties.
- Published in:
- Human & Experimental Toxicology, 2023, v. 42, p. 1, doi. 10.1177/09603271231218926
- By:
- Publication type:
- Article
Comments on the optimal use of medical ozone in clinics versus the Ozone High Dose Therapy (OHT) approach.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Commentary: Ozone therapy as a novel complementary therapeutic approach in refractory idiopathic granulomatous mastitis.
- Published in:
- Frontiers in Medicine, 2023, p. 1, doi. 10.3389/fmed.2023.1272059
- By:
- Publication type:
- Article
The Role of Ozone as an Nrf2-Keap1-ARE Activator in the Anti-Microbial Activity and Immunity Modulation of Infected Wounds.
- Published in:
- Antioxidants, 2023, v. 12, n. 11, p. 1985, doi. 10.3390/antiox12111985
- By:
- Publication type:
- Article
The Oxygen–Ozone Adjunct Medical Treatment According to the Protocols from the Italian Scientific Society of Oxygen–Ozone Therapy: How Ozone Applications in the Blood Can Influence Clinical Therapy Success via the Modulation of Cell Biology and Immunity
- Published in:
- Biology (2079-7737), 2023, v. 12, n. 12, p. 1512, doi. 10.3390/biology12121512
- By:
- Publication type:
- Article
Adjunct treatment with ozone to enhance therapy of knee osteoarthritis: preliminary results.
- Published in:
- Clinical Rheumatology, 2024, v. 43, n. 6, p. 2093, doi. 10.1007/s10067-024-06972-x
- By:
- Publication type:
- Article
The Mito-Hormetic Mechanisms of Ozone in the Clearance of SARS-CoV2 and in the COVID-19 Therapy.
- Published in:
- Biomedicines, 2022, v. 10, n. 9, p. 2258, doi. 10.3390/biomedicines10092258
- By:
- Publication type:
- Article
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis of Early COVID-19 and Treated at Home Within 3 Days or After 3 Days of Symptom Onset with Prescribed and Non-Prescribed Treatments Between...
- Published in:
- Medical Science Monitor, 2021, v. 27, p. e935379-1, doi. 10.12659/MSM.935379
- By:
- Publication type:
- Article
Home pharmacological therapy in early COVID‐19 to prevent hospitalization and reduce mortality: Time for a suitable proposal.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2022, v. 130, n. 2, p. 225, doi. 10.1111/bcpt.13690
- By:
- Publication type:
- Article
Home therapy of COVID‐19 at the earliest may greatly prevent hospitalization.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2021, v. 129, n. 6, p. 395, doi. 10.1111/bcpt.13650
- By:
- Publication type:
- Article
Comments on "To clarify the safety profile of paracetamol for home-care patients with COVID-19: a real-world cohort study, with nested case–control analysis, in primary care".
- Published in:
- 2023
- By:
- Publication type:
- Letter
The need for a correct oxygen-ozone autohemotherapy (O3-AHT) in patients with mild to moderate COVID-19 pneumonia.
- Published in:
- 2021
- By:
- Publication type:
- Letter